InnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese Contractors [Forbes]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Forbes
ccording to the American Society of Health System Pharmacists , 323 drugs are currently experiencing shortages in the United States, the highest number the organization has seen since it began recording drug shortages in 2001. These include chemotherapies, ADHD medications, oxytocin and more. And the threat of shortages has a chance to be exacerbated further, at least in the short term, due to pending bipartisan legislation in both houses called the BIOSECURE Act ,. If enacted, it might prevent American companies from working with key Chinese biotech contractors like WuXi AppTec, WuXi Biologics and MGI Tech. Stock prices have fallen significantly for these companies since the bill was introduced, and drug companies have warned investors that passage of the bill could have manufacturing impacts as well as cause delay in clinical trials. Defenders of the bill say that this will ultimately improve competition – and decrease reliance on China. “We have seen this play before with Huawei
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy [Yahoo! Finance Canada]Yahoo! Finance Canada
- Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes [Reuters]Reuters
- Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk's market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk' for Denmark [Fortune]Fortune
- Novo Nordisk owner to invest $200 million in quantum computing startups [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/3/23 - Beat
NVO
Sec Filings
- 4/26/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/25/24 - Form 6-K
- NVO's page on the SEC website